White matter microstructural damage in alzheimer's disease at different ages of onset

Neurobiology of Aging

Volumn 34, Issue 10, 2013, Pages 2331-2340

  Canu, Elisa ^a   Agosta, Federica ^a   Spinelli, Edoardo G ^a,b   Magnani, Giuseppe ^b   Marcone, Alessandra ^a   Scola, Elisa ^a   Falautano, Monica ^b   Comi, Giancarlo ^b   Falini, Andrea ^a   Filippi, Massimo ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Diffusion tensor MRI; Early onset Alzheimer's disease; Late onset Alzheimer's disease; MRI; White matter damage

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FEMALE; FRONTAL CORTEX; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARIETAL CORTEX; PRIORITY JOURNAL; TEMPORAL CORTEX; TRACTOGRAPHY; VOXEL BASED MORPHOMETRY; WHITE MATTER INJURY;

DIFFUSION TENSOR MRI; EARLY-ONSET ALZHEIMER'S DISEASE; LATE-ONSET ALZHEIMER'S DISEASE; MRI; WHITE MATTER DAMAGE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN MAPPING; CEREBRAL CORTEX; CORPUS CALLOSUM; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84879889389     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.03.026     Document Type: Article

References (52)

1. Agosta F., Pievani M., Sala S., Geroldi C., Galluzzi S., Frisoni G.B., Filippi M. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 2011, 258:853-863.
2. Ashburner J. Afast diffeomorphic image registration algorithm. NeuroImage 2007, 38:95-113.
3. Basso A., Capitani E., Laiacona M. Raven's coloured progressive matrices: normative values on 305 adult normal controls. Funct. Neurol. 1987, 2:189-194.
4. Behrens T.E., Berg H.J., Jbabdi S., Rushworth M.F., Woolrich M.W. Probabilistic diffusion tractography with multiple fibre orientations: what can we gain?. NeuroImage 2007, 34:144-155.
5. Benedetti B., Charil A., Rovaris M., Judica E., Valsasina P., Sormani M.P., Filippi M. Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI. Neurology 2006, 66:535-539.
6. Bigio E.H., Hynan L.S., Sontag E., Satumtira S., White C.L. Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol. Appl. Neurobiol. 2002, 28:218-227.
7. Bosch B., Arenaza-Urquijo E.M., Rami L., Sala-Llonch R., Junque C., Sole-Padulles C., Pena-Gomez C., Bargallo N., Molinuevo J.L., Bartres-Faz D. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol. Aging 2012, 33:61-74.
8. Bouwman F.H., Schoonenboom N.S., Verwey N.A., van Elk E.J., Kok A., Blankenstein M.A., Scheltens P., van der Flier W.M. CSF biomarker levels in early and late onset Alzheimer's disease. Neurobiol. Aging 2009, 30:1895-1901.
9. Bozzali M., Giulietti G., Basile B., Serra L., Spano B., Perri R., Giubilei F., Marra C., Caltagirone C., Cercignani M. Damage to the cingulum contributes to Alzheimer's disease pathophysiology by deafferentation mechanism. Hum. Brain Mapp. 2012, 33:1295-1308.
10. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
11. Caffarra P., Vezzadini G., Dieci F., Zonato F., Venneri A. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol. Sci. 2002, 22:443-447.
12. Canu E., Frisoni G.B., Agosta F., Pievani M., Bonetti M., Filippi M. Early and late onset Alzheimer's disease patients have distinct patterns of white matter damage. Neurobiol. Aging 2012, 33:1023-1033.
13. De Renzi E., Faglioni P. Normative data and screening power of a shortened version of the Token Test. Cortex 1978, 14:41-49.
14. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
15. Frisoni G.B., Pievani M., Testa C., Sabattoli F., Bresciani L., Bonetti M., Beltramello A., Hayashi K.M., Toga A.W., Thompson P.M. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 2007, 130:720-730.
16. Frisoni G.B., Testa C., Sabattoli F., Beltramello A., Soininen H., Laakso M.P. Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J.Neurol. Neurosurg. Psychiatry 2005, 76:112-114.
17. Galluzzi S., Testa C., Boccardi M., Bresciani L., Benussi L., Ghidoni R., Beltramello A., Bonetti M., Bono G., Falini A., Magnani G., Minonzio G., Piovan E., Binetti G., Frisoni G.B. The Italian Brain Normative Archive of structural MR scans: norms for medial temporal atrophy and white matter lesions. Aging Clin. Exp. Res. 2009, 21:266-276.
18. Hanyu H., Nakano S., Abe S., Arai H., Iwamoto T., Takasaki M. [Differences of neuroimaging between early-onset and late-onset Alzheimer-type dementia]. Rinsho Shinkeigaku 1995, 35:1104-1109.
19. Hirono N., Hashimoto M., Yasuda M., Ishii K., Sakamoto S., Kazui H., Mori E. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset. Neurology 2002, 58:743-750.
20. Ho G.J., Hansen L.A., Alford M.F., Foster K., Salmon D.P., Galasko D., Thal L.J., Masliah E. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport 2002, 13:1825-1828.
21. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. Anew clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
22. Ishii K., Kawachi T., Sasaki H., Kono A.K., Fukuda T., Kojima Y., Mori E. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am. J. Neuroradiol. 2005, 26:333-340.
23. Kim E.J., Cho S.S., Jeong Y., Park K.C., Kang S.J., Kang E., Kim S.E., Lee K.H., Na D.L. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain 2005, 128:1790-1801.
24. Marshall G.A., Fairbanks L.A., Tekin S., Vinters H.V., Cummings J.L. Early-onset Alzheimer's disease is associated with greater pathologic burden. J.Geriatr. Psychiatry Neurol. 2007, 20:29-33.
25. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
26. Medina D.A., Gaviria M. Diffusion tensor imaging investigations in Alzheimer's disease: the resurgence of white matter compromise in the cortical dysfunction of the aging brain. Neuropsychiatr. Dis. Treat. 2008, 4:737-742.
27. Migliaccio R., Agosta F., Possin K.L., Rabinovici G.D., Miller B.L., Gorno-Tempini M.L. White matter atrophy in Alzheimer's disease variants. Alzheimers Dement 2012, 8 (5 Suppl), S78-87.
28. Migliaccio R., Agosta F., Rascovsky K., Karydas A., Bonasera S., Rabinovici G.D., Miller B.L., Gorno-Tempini M.L. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology 2009, 73:1571-1578.
29. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002, 15:1-25.
30. Nochlin D., van Belle G., Bird T.D., Sumi S.M. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 1993, 7:212-222.
31. Novelli G., Papagno C., Capitani E., Laiacona M., Vallar G., Cappa S. Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Archivio di Psicologia, Neurologia e Psichiatria 1986, 47:477-506.
32. Orsini A., Grossi D., Capitani E., Laiacona M., Papagno C., Vallar G. Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital. J. Neurol. Sci. 1987, 8:539-548.
33. Ossenkoppele R., Zwan M.D., Tolboom N., van Assema D.M., Adriaanse S.F., Kloet R.W., Boellaard R., Windhorst A.D., Barkhof F., Lammertsma A.A., Scheltens P., van der Flier W.M., van Berckel B.N. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Brain 2012, 135:2115-2125.
34. Pagani E., Agosta F., Rocca M.A., Caputo D., Filippi M. Voxel-based analysis derived from fractional anisotropy images of white matter volume changes with aging. NeuroImage 2008, 41:657-667.
35. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M. ABayesian model of shape and appearance for subcortical brain segmentation. NeuroImage 2011, 56:907-922.
36. Pierpaoli C., Barnett A., Pajevic S., Chen R., Penix L.R., Virta A., Basser P. Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. NeuroImage 2001, 13:1174-1185.
37. Rabinovici G.D., Furst A.J., Alkalay A., Racine C.A., O'Neil J.P., Janabi M., Baker S.L., Agarwal N., Bonasera S.J., Mormino E.C., Weiner M.W., Gorno-Tempini M.L., Rosen H.J., Miller B.L., Jagust W.J. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 2010, 133:512-528.
38. Rabinovici G.D., Seeley W.W., Kim E.J., Gorno-Tempini M.L., Rascovsky K., Pagliaro T.A., Allison S.C., Halabi C., Kramer J.H., Johnson J.K., Weiner M.W., Forman M.S., Trojanowski J.Q., Dearmond S.J., Miller B.L., Rosen H.J. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am. J. Alzheimers Dis. Other Dement. 2007, 22:474-488.
39. Rossor M.N., Fox N.C., Mummery C.J., Schott J.M., Warren J.D. The diagnosis of young-onset dementia. Lancet Neurol. 2010, 9:793-806.
40. Sexton C.E., Kalu U.G., Filippini N., Mackay C.E., Ebmeier K.P. Ameta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2011, 32:2322.e5-2322.e18.
41. Sjobeck M., Haglund M., Englund E. White matter mapping in Alzheimer's disease: a neuropathological study. Neurobiol. Aging 2006, 27:673-680.
42. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., Behrens T.E. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 2006, 31:1487-1505.
43. Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 2009, 44:83-98.
44. Smits L.L., Pijnenburg Y.A., Koedam E.L., van der Vlies A.E., Reuling I.E., Koene T., Teunissen C.E., Scheltens P., van der Flier W.M. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. J.Alzheimers Dis. 2012, 30:101-108.
45. Spinnler H., Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital. J. Neurol. Sci. 1987, 8:1-120.
46. Villain N., Desgranges B., Viader F., de la Sayette V., Mezenge F., Landeau B., Baron J.C., Eustache F., Chetelat G. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J.Neurosci. 2008, 28:6174-6181.
47. Wahlund L.O., Barkhof F., Fazekas F., Bronge L., Augustin M., Sjogren M., Wallin A., Ader H., Leys D., Pantoni L., Pasquier F., Erkinjuntti T., Scheltens P. Anew rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001, 32:1318-1322.
48. Wheeler-Kingshott C.A., Cercignani M. About "axial" and "radial" diffusivities. Magn. Reson. Med. 2009, 61:1255-1260.
49. Wisniewski H.M., Bancher C., Barcikowska M., Wen G.Y., Currie J. Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol. 1989, 78:337-347.
50. Xie S., Xiao J.X., Wang Y.H., Wu H.K., Gong G.L., Jiang X.X. Evaluation of bilateral cingulum with tractography in patients with Alzheimer's disease. Neuroreport 2005, 16:1275-1278.
51. Xu J., Chen S., Ahmed S.H., Chen H., Ku G., Goldberg M.P., Hsu C.Y. Amyloid-beta peptides are cytotoxic to oligodendrocytes. J.Neurosci. 2001, 21:RC118.
52. Zhuang L., Sachdev P.S., Trollor J.N., Kochan N.A., Reppermund S., Brodaty H., Wen W. Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI. Neurology 2012, 79:748-754.